Shionogi and Ferrer conclude a contract for the promotion in Spain of▼ Rizmoic® (naldemedine), a therapeutic agent for opioid-induced constipation
24 Jun 2019
19.06.2019 Shionogi and Ferrer conclude a contract for the promotion in Spain of▼ Rizmoic® (naldemedine), a therapeutic agent for opioid-induced constipation
© Shionogi B.V. 2019. All rights reserved. This website is owned by Shionogi B.V. Registered with the Trade Register of the Dutch Chamber of Commerce under number 73229180. Registered address is Kingsfordweg 151, 1043GR, Amsterdam, the Netherlands.
Report Side Effect
Just to let you know, you are now moving to another website this is not under our control and Shionogi B.V. is not responsible for its contents.